FI961900A - Process for Preparation of Virus Inactivated Factor VIII Containing Fraction by Chromatographic Procedures - Google Patents
Process for Preparation of Virus Inactivated Factor VIII Containing Fraction by Chromatographic Procedures Download PDFInfo
- Publication number
- FI961900A FI961900A FI961900A FI961900A FI961900A FI 961900 A FI961900 A FI 961900A FI 961900 A FI961900 A FI 961900A FI 961900 A FI961900 A FI 961900A FI 961900 A FI961900 A FI 961900A
- Authority
- FI
- Finland
- Prior art keywords
- factor viii
- containing fraction
- preparation
- chromatographic procedures
- virus inactivated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A process for producing a virus-inactivated, factor VIII-containing fraction by chromatographic methods in which, starting with cryoprecipitate or blood plasma, possibly followed by a treatment with aluminium hydroxide, at least one separating operation is performed by membrane chromatography after the dissolution of the cryoprecipitate. The fractions are subjected to virus inactivation and preferably an additional pasteurisation step.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4337573 | 1993-11-04 | ||
DE4337573A DE4337573C1 (en) | 1993-11-04 | 1993-11-04 | Process for the preparation of a virus-inactivated factor VIII-containing fraction by means of chromatographic methods |
PCT/EP1994/003258 WO1995012609A1 (en) | 1993-11-04 | 1994-09-30 | Process for producing a virus-inactivated factor viii-containing fraction by chromatographic methods |
EP9403258 | 1994-09-30 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI961900A true FI961900A (en) | 1996-05-03 |
FI961900A0 FI961900A0 (en) | 1996-05-03 |
FI116569B FI116569B (en) | 2005-12-30 |
Family
ID=6501733
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI961900A FI116569B (en) | 1993-11-04 | 1996-05-03 | Method for Preparation of Virus-Activated Factor VIII-Containing Fraction by Chromatographic Methods |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0726907B1 (en) |
JP (1) | JP3739788B2 (en) |
KR (1) | KR960705841A (en) |
CN (1) | CN1109045C (en) |
AT (1) | ATE228533T1 (en) |
AU (1) | AU687451B2 (en) |
CA (1) | CA2175670C (en) |
CZ (1) | CZ290186B6 (en) |
DE (2) | DE4337573C1 (en) |
ES (1) | ES2182846T3 (en) |
FI (1) | FI116569B (en) |
HU (1) | HU222087B1 (en) |
IL (1) | IL111263A (en) |
MY (1) | MY113294A (en) |
NO (1) | NO317112B1 (en) |
PL (1) | PL181725B1 (en) |
RU (1) | RU2148411C1 (en) |
SK (1) | SK284215B6 (en) |
UA (1) | UA43855C2 (en) |
WO (1) | WO1995012609A1 (en) |
ZA (1) | ZA948667B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19618851C1 (en) * | 1996-05-10 | 1997-07-24 | Octapharma Ag | Testing factor VIII containing preparations |
US6057164A (en) * | 1996-03-08 | 2000-05-02 | Octapharma Ag | Process for testing suitability of protein fractions containing factor VIII |
ES2137878B1 (en) * | 1997-12-01 | 2000-10-01 | Grifols Grupo Sa | PROCEDURE FOR OBTAINING AN ATTENUATED HUMAN PLASMA OF VIRUSES FOR THERAPEUTIC USE. |
CN102066417B (en) | 2008-06-24 | 2015-11-25 | 奥克塔法马股份有限公司 | The method of purification and solidification Factor IX |
AU2011343813B2 (en) | 2010-12-15 | 2015-05-21 | Takeda Pharmaceutical Company Limited | Eluate collection using conductivity gradient |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4540573A (en) * | 1983-07-14 | 1985-09-10 | New York Blood Center, Inc. | Undenatured virus-free biologically active protein derivatives |
DE3432083A1 (en) * | 1984-08-31 | 1986-03-06 | Behringwerke Ag, 3550 Marburg | PASTEURIZED, ISOAGGLUTININ-FREE FACTOR VIII PREPARATION AND METHOD FOR THE PRODUCTION THEREOF |
US5043428A (en) * | 1984-08-31 | 1991-08-27 | Behringwerke Aktiengesellschaft | Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production |
JPS62191042A (en) * | 1986-02-17 | 1987-08-21 | Kanegafuchi Chem Ind Co Ltd | Blood coagulation factor viii adsorbent and method for purifying blood coagulation factor viii using same |
CA1339946C (en) * | 1987-03-31 | 1998-07-07 | Michael J. Griffith | Ultrapurification process for polypeptides |
US4774323A (en) * | 1987-06-29 | 1988-09-27 | Rorer Pharmaceutical Corporation | Purification of von Willebrand Factor solutions using gel permeation chromatography |
US4795806A (en) * | 1987-07-16 | 1989-01-03 | Miles Laboratories, Inc. | Phospholipid affinity purification of Factor VIII:C |
CA2001720C (en) * | 1988-10-31 | 2001-10-02 | Randal A. Goffe | Membrane affinity apparatus and purification methods related thereto |
EP0367840B1 (en) * | 1988-11-05 | 1993-02-03 | Octapharma AG | Process for producing by chromatography a non-infectious antihemophilic factor with high purity |
CH678155A5 (en) * | 1989-08-09 | 1991-08-15 | Fischer Ag Georg | |
AT399818B (en) * | 1992-04-24 | 1995-07-25 | Immuno Ag | METHOD FOR PRODUCING A HIGH PURIFIED VIRUS-SAFE FACTOR VIII PREPARATION |
-
1993
- 1993-11-04 DE DE4337573A patent/DE4337573C1/en not_active Revoked
-
1994
- 1994-09-30 KR KR1019960702337A patent/KR960705841A/en not_active Application Discontinuation
- 1994-09-30 UA UA96041756A patent/UA43855C2/en unknown
- 1994-09-30 JP JP51297795A patent/JP3739788B2/en not_active Expired - Fee Related
- 1994-09-30 AU AU78109/94A patent/AU687451B2/en not_active Expired
- 1994-09-30 CZ CZ19961187A patent/CZ290186B6/en not_active IP Right Cessation
- 1994-09-30 PL PL94314185A patent/PL181725B1/en not_active IP Right Cessation
- 1994-09-30 RU RU96110890A patent/RU2148411C1/en not_active IP Right Cessation
- 1994-09-30 DE DE59410213T patent/DE59410213D1/en not_active Expired - Lifetime
- 1994-09-30 HU HU9601192A patent/HU222087B1/en not_active IP Right Cessation
- 1994-09-30 ES ES94928846T patent/ES2182846T3/en not_active Expired - Lifetime
- 1994-09-30 CN CN94194020A patent/CN1109045C/en not_active Expired - Fee Related
- 1994-09-30 SK SK566-96A patent/SK284215B6/en not_active IP Right Cessation
- 1994-09-30 CA CA002175670A patent/CA2175670C/en not_active Expired - Fee Related
- 1994-09-30 WO PCT/EP1994/003258 patent/WO1995012609A1/en active IP Right Grant
- 1994-09-30 AT AT94928846T patent/ATE228533T1/en active
- 1994-09-30 EP EP94928846A patent/EP0726907B1/en not_active Expired - Lifetime
- 1994-10-12 IL IL11126394A patent/IL111263A/en not_active IP Right Cessation
- 1994-11-03 ZA ZA948667A patent/ZA948667B/en unknown
- 1994-11-03 MY MYPI94002921A patent/MY113294A/en unknown
-
1996
- 1996-05-03 FI FI961900A patent/FI116569B/en active IP Right Grant
- 1996-05-03 NO NO19961816A patent/NO317112B1/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA27732C2 (en) | Process for preparation of a standardized human von willebrand factor concentrate and a concentrate prepared thereby | |
GR3003819T3 (en) | ||
CA2034489A1 (en) | Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions | |
DE69002395D1 (en) | N-TERMINAL FRAGMENTS OF FUSION PROTEINS CONTAINING HUMAN SERUM ALBUMINE. | |
DK0429570T3 (en) | Osteoinducing preparations | |
UA11061A (en) | Method for separating proteins of blood | |
NO951761L (en) | Stable preparation for the treatment of blood coagulation disorders | |
DE3479583D1 (en) | High titer cytomegalovirus human immune serum globulin and method of making same | |
AU627618B2 (en) | Process for preparing a concentrate of blood coagulation factor v111-von willebrand factor complex from total plasma | |
FI961900A (en) | Process for Preparation of Virus Inactivated Factor VIII Containing Fraction by Chromatographic Procedures | |
UA35639C2 (en) | Method for obtaining of composition of purified core protein of human papilloma virus. | |
AU561222B2 (en) | Process for the pasteurization of human plasma | |
ES2173927T3 (en) | PROCEDURE FOR THE PREPARATION OF AN INTER-ALFA-TRIPSIN CONCENTRATE INHIBITOR FOR THERAPEUTIC USE, AND CONCENTRATE OBTAINED. | |
FI903366A0 (en) | FOERFARANDE FOER FRAMSTAELLNING AV EN MYCKET REN ICKE INFEKTIOES ANTIHEMOFILIFAKTOR GENOM KROMATOGRAFI. | |
AR018260A1 (en) | A PROCESS TO PREPARE A GAMMAGLOBULIN SOLUTION THAT CAN BE ADMINISTERED INTRAVENOUSLY, AND GAMMAGLOBULIN SOLUTION OBTAINED BY DICHOPROCESS | |
GR3005036T3 (en) | ||
PT733104E (en) | PURIFICATION OF VITAMIN K DEPENDENT PROTEINS BY MEMBRANE CHROMATOGRAPHY | |
ATE329602T1 (en) | METHOD FOR PRODUCING PURIFIED TRANSFERRIN | |
AU4811290A (en) | A pure factor i protein and a process for producing said protein | |
ES2094701A1 (en) | Process for the production of antithrombin III | |
UA13922A (en) | Method for producing of contrinsulinic factor, blocking of insulin binding with its receptor and having of diabetogenic action | |
RU95108777A (en) | Method to correct presbyopia along with mixed astigmatism |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 116569 Country of ref document: FI |